240 related articles for article (PubMed ID: 11369850)
21. Structure and ligand binding determinants of the recombinant kringle 5 domain of human plasminogen.
Chang Y; Mochalkin I; McCance SG; Cheng B; Tulinsky A; Castellino FJ
Biochemistry; 1998 Mar; 37(10):3258-71. PubMed ID: 9521645
[TBL] [Abstract][Full Text] [Related]
22. Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein.
Rios-Steiner JL; Schenone M; Mochalkin I; Tulinsky A; Castellino FJ
J Mol Biol; 2001 May; 308(4):705-19. PubMed ID: 11350170
[TBL] [Abstract][Full Text] [Related]
23. Specificity determinants in the interaction of apolipoprotein(a) kringles with tetranectin and LDL.
Caterer NR; Graversen JH; Jacobsen C; Moestrup SK; Sigurskjold BW; Etzerodt M; Thøgersen HC
Biol Chem; 2002 Nov; 383(11):1743-50. PubMed ID: 12530539
[TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein(a), through its strong lysine-binding site in KIV(10'), mediates increased endothelial cell contraction and permeability via a Rho/Rho kinase/MYPT1-dependent pathway.
Cho T; Jung Y; Koschinsky ML
J Biol Chem; 2008 Nov; 283(45):30503-12. PubMed ID: 18776185
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms in human apolipoprotein(a) kringle IV-10 and coronary artery disease: relationship to allele size, plasma lipoprotein(a) concentration, and lysine binding site activity.
Simó JM; Joven J; Vilella E; Ribas M; Figuera L; Virgos C; Sundaram IM; Hoover-Plow J
J Mol Med (Berl); 2001 Jun; 79(5-6):294-9. PubMed ID: 11485023
[TBL] [Abstract][Full Text] [Related]
26. Lys and fibrinogen binding of wild-type (Trp72) and mutant (Arg72) human apo(a) kringle IV-10 expressed in E coli and CHO cells.
Klezovitch O; Scanu AM
Arterioscler Thromb Vasc Biol; 1996 Mar; 16(3):392-8. PubMed ID: 8630665
[TBL] [Abstract][Full Text] [Related]
27. Protein-ligand interactions in the lysine-binding site of plasminogen kringle 4 are different in crystal and solution. Electrostatic interactions studied by site-directed mutagenesis exclude Lys35 as an important acceptor in solution.
Nielsen PR; Einer-Jensen K; Holtet TL; Andersen BD; Poulsen FM; Thøgersen HC
Biochemistry; 1993 Dec; 32(48):13019-25. PubMed ID: 8241155
[TBL] [Abstract][Full Text] [Related]
28. Lysine-50 is a likely site for anchoring the plasminogen N-terminal peptide to lysine-binding kringles.
An SS; Carreño C; Marti DN; Schaller J; Albericio F; Llinas M
Protein Sci; 1998 Sep; 7(9):1960-9. PubMed ID: 9761476
[TBL] [Abstract][Full Text] [Related]
29. Crystal structures of apolipoprotein(a) kringle IV37 free and complexed with 6-aminohexanoic acid and with p-aminomethylbenzoic acid: existence of novel and expected binding modes.
Mikol V; LoGrasso PV; Boettcher BR
J Mol Biol; 1996 Mar; 256(4):751-61. PubMed ID: 8642595
[TBL] [Abstract][Full Text] [Related]
30. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
Sangrar W; Gabel BR; Boffa MB; Walker JB; Hancock MA; Marcovina SM; Horrevoets AJ; Nesheim ME; Koschinsky ML
Biochemistry; 1997 Aug; 36(34):10353-63. PubMed ID: 9265615
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the mechanism of lipoprotein(a) assembly.
Koschinsky ML; Marcovina SM; May LF; Gabel BR
Clin Genet; 1997 Nov; 52(5):338-46. PubMed ID: 9520124
[TBL] [Abstract][Full Text] [Related]
32. Expression of apolipoprotein(a) kringle IV type 9 in Escherichia coli: demonstration of a specific interaction between kringle IV type 9 and apolipoproteinB-100.
Rahman M; Jia Z; Gabel BR; Marcovina SM; Koschinsky ML
Protein Eng; 1998 Dec; 11(12):1249-56. PubMed ID: 9930675
[TBL] [Abstract][Full Text] [Related]
33. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site.
Ahn JH; Lee HJ; Lee EK; Yu HK; Lee TH; Yoon Y; Kim SJ; Kim JS
Biol Chem; 2011 Apr; 392(4):347-56. PubMed ID: 21194375
[TBL] [Abstract][Full Text] [Related]
34. Comparison of ligand-binding sites of modeled apo[a] kringle-like sequences in human lipoprotein[a].
Guevara J; Jan AY; Knapp R; Tulinsky A; Morrisett JD
Arterioscler Thromb; 1993 May; 13(5):758-70. PubMed ID: 8387333
[TBL] [Abstract][Full Text] [Related]
35. Tetranectin-binding site on plasminogen kringle 4 involves the lysine-binding pocket and at least one additional amino acid residue.
Graversen JH; Sigurskjold BW; Thøgersen HC; Etzerodt M
Biochemistry; 2000 Jun; 39(25):7414-9. PubMed ID: 10858289
[TBL] [Abstract][Full Text] [Related]
36. Solution structure and dynamics of the plasminogen kringle 2-AMCHA complex: 3(1)-helix in homologous domains.
Marti DN; Schaller J; Llinás M
Biochemistry; 1999 Nov; 38(48):15741-55. PubMed ID: 10625440
[TBL] [Abstract][Full Text] [Related]
37. Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody.
Kang C; Dominguez M; Loyau S; Miyata T; Durlach V; Anglés-Cano E
Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1232-8. PubMed ID: 12117743
[TBL] [Abstract][Full Text] [Related]
38. Apo(a)-kringle IV-type 6: expression in Escherichia coli, purification and in vitro refolding.
Hrzenjak A; Frank S; Maderegger B; Sterk H; Kostner GM
Protein Eng; 2000 Sep; 13(9):661-6. PubMed ID: 11054461
[TBL] [Abstract][Full Text] [Related]
39. Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin.
Arni RK; Padmanabhan K; Padmanabhan KP; Wu TP; Tulinsky A
Biochemistry; 1993 May; 32(18):4727-37. PubMed ID: 8387813
[TBL] [Abstract][Full Text] [Related]
40. Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins.
Trieu VN; Zioncheck TF; Lawn RM; McConathy WJ
J Biol Chem; 1991 Mar; 266(9):5480-5. PubMed ID: 1848551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
